{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:48:18Z","timestamp":1786978098168,"version":"build-2736575974"},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Crimean\u2010Congo hemorrhagic fever (CCHF) is a viral hemorrhagic fever, which is common in Turkey and globally. The pathogenesis of coagulation disorders, which is seen in viral hemorrhagic fevers remains to be elucidated. Thrombin\u2010activatable fibrinolysis inhibitor (TAFI) has a key role in this process In this study, we aimed to evaluate whether TAFI levels contributed to bleeding and whether it is related to prognosis in CCHF patients.\u00a0Eighty\u2010four patients older than 15 years of age, who were admitted to our hospital who had positive immunoglobulin M (enzyme\u2010linked immunosorbent assay [ELISA]) and\/or polymerase chain reaction test results for CCHF between 2009 and 2010, were included in the study. The control group included 30 healthy adults. The plasma TAFI levels were compared between patients and controls, and also between patients with bleeding and no bleeding, and between patients with mild\u2010moderate and severe disease. The mean TAFI levels were lower in patients (mean: 87.82\u2009ng\/ml, median: 61.69\u2009ng\/ml (interquartile range [IQR] 30.49\u2013537.95) than controls (mean: 313.5\u2009ng\/ml with a median: 338.5\u2009ng\/ml (IQR 182\u2013418). However, median TAFI levels were significantly higher in patients with bleeding compared to those without bleeding (78.99 and 50.28\u2009ng\/ml, respectively;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.032). Median IQR TAFI levels were similar between patients with mild\u2010moderate and severe disease (64.72 (41.37\u2013113.85), and, 58.66 (42.44\u2013118.93) ng\/ml, respectively;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.09) and survivors and nonsurvivors (86.14\u2009\u00b1\u200977.98 and 103.48\u2009\u00b1\u200969.92, respectively;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.3). Although TAFI levels were lower in the patients with CCHF compared to healthy controls, it does not seem to be a major player in the prognosis.\n                  <\/jats:p>","DOI":"10.1002\/jmv.28182","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T20:28:59Z","timestamp":1664483339000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Serum thrombin\u2010activatable fibrinolysis inhibitor levels and its relation with\n                    <i>pathogenesis and bleeding and prognosis<\/i>\n                    in patients with Crimean Congo hemorrhagic fever"],"prefix":"10.1002","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6211-712X","authenticated-orcid":false,"given":"Nilgun","family":"Altin","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, D\u0131\u015fkap\u0131 Y\u0131ld\u0131r\u0131m Beyaz\u0131t Training and Research Hospital University of Health Sciences Ankara Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Aybala","family":"Altay","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, D\u0131\u015fkap\u0131 Y\u0131ld\u0131r\u0131m Beyaz\u0131t Training and Research Hospital University of Health Sciences Ankara Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Albayrak","sequence":"additional","affiliation":[{"name":"Department of Hematology University of Health Sciences D\u0131\u015fkap\u0131 Y\u0131ld\u0131r\u0131m Beyaz\u0131t Training and Research Hospital Ankara Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyda Ozdemir","family":"Sahingoz","sequence":"additional","affiliation":[{"name":"Department of Biochemistry University of Health Sciences D\u0131\u015fkap\u0131 Y\u0131ld\u0131r\u0131m Beyaz\u0131t Training and Research Hospital Ankara Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Sencan","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, D\u0131\u015fkap\u0131 Y\u0131ld\u0131r\u0131m Beyaz\u0131t Training and Research Hospital University of Health Sciences Ankara Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,10,8]]},"reference":[{"key":"e_1_2_10_2_1","unstructured":"CCHF Statistical Data.2021. Turkey.https:\/\/hsgm.saglik.gov.tr\/tr\/zoonotikvektorel-kkka"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2015.12.003"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid0606.000608"},{"key":"e_1_2_10_5_1","first-page":"234","article-title":"KIRIM KONGO KANAMALI ATE\u015e\u0130","volume":"23","author":"Erg\u00f6n\u00fcl \u00d6","year":"2009","journal-title":"Ankem"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/11.Supplement_4.S794"},{"key":"e_1_2_10_7_1","first-page":"235","article-title":"Plasma levels of Plasminogen Activator Inhibitor\u20101 (PAI\u20101) and thrombin activatable fibrinolysis inhibitor (TAFI) in patients with disseminated intravascular coagulation (DIC)","volume":"19","author":"Wada H","year":"2002","journal-title":"Turk J Haematol"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mbc.0000181175.62437.2a"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2007.02.010"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2012.1061"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-777X.83537"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1142"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200205001-00016"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.24.14477"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)54713-X"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30112-4"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.3906\/sag-1812-231"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2005.12.008"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/1076029606291403"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8214"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2004.09.010"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-008-9116-4"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/1076029609350890"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200108093450603"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002919"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1086\/422000"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2006.01445.x"},{"key":"e_1_2_10_28_1","first-page":"147","article-title":"Prealbumin rather than albumin is a more sensitive indicator of acute liver disease","volume":"15","author":"Yasmin MY","year":"1993","journal-title":"Malays J Pathol"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.28182","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jmv.28182","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.28182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T08:48:05Z","timestamp":1772959685000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.28182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,8]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1002\/jmv.28182"],"URL":"https:\/\/doi.org\/10.1002\/jmv.28182","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,8]]},"assertion":[{"value":"2022-05-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e28182"}}